Efficacy evaluation of an herbal compound in COVID-19

Phase 2

• Conditions: COVID-19.; COVID-19; U07.1

• Registration Number: IRCT20200323046841N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Hospitalized patients with clinical and CT scan findings strongly suspected of COVID -19
Relative stability in cardiovascular status
Moderate and severe cases
No organ damage

Exclusion Criteria

Pregnant and lactating women
End stage patients

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Changing the patient's clinical status in the COVID-19 clinical classification table. Timepoint: Before and after intervention. Method of measurement: Clinical and Paraclinical Indicators in COVID-19 Classification Table.

Secondary Outcome Measures

Name	Time	Method
Cell blood count. Timepoint: Before and after the intervention. Method of measurement: Cell conuter.;Liver enzymes. Timepoint: Before and after the intervention. Method of measurement: spectrometer.